List of Tables
Table 1. Global Targeted Drug HER2 Inhibitors for NSCLC Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Afatinib
Table 3. Key Players of Trastuzumab
Table 4. Key Players of Others
Table 5. Global Targeted Drug HER2 Inhibitors for NSCLC Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Targeted Drug HER2 Inhibitors for NSCLC Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Targeted Drug HER2 Inhibitors for NSCLC Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Targeted Drug HER2 Inhibitors for NSCLC Market Share by Region (2020-2025)
Table 9. Global Targeted Drug HER2 Inhibitors for NSCLC Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Targeted Drug HER2 Inhibitors for NSCLC Market Share by Region (2026-2031)
Table 11. Targeted Drug HER2 Inhibitors for NSCLC Market Trends
Table 12. Targeted Drug HER2 Inhibitors for NSCLC Market Drivers
Table 13. Targeted Drug HER2 Inhibitors for NSCLC Market Challenges
Table 14. Targeted Drug HER2 Inhibitors for NSCLC Market Restraints
Table 15. Global Targeted Drug HER2 Inhibitors for NSCLC Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Targeted Drug HER2 Inhibitors for NSCLC Market Share by Players (2020-2025)
Table 17. Global Top Targeted Drug HER2 Inhibitors for NSCLC Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Targeted Drug HER2 Inhibitors for NSCLC as of 2024)
Table 18. Ranking of Global Top Targeted Drug HER2 Inhibitors for NSCLC Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Targeted Drug HER2 Inhibitors for NSCLC Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Targeted Drug HER2 Inhibitors for NSCLC, Headquarters and Area Served
Table 21. Global Key Players of Targeted Drug HER2 Inhibitors for NSCLC, Product and Application
Table 22. Global Key Players of Targeted Drug HER2 Inhibitors for NSCLC, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Targeted Drug HER2 Inhibitors for NSCLC Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Targeted Drug HER2 Inhibitors for NSCLC Revenue Market Share by Type (2020-2025)
Table 26. Global Targeted Drug HER2 Inhibitors for NSCLC Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Targeted Drug HER2 Inhibitors for NSCLC Revenue Market Share by Type (2026-2031)
Table 28. Global Targeted Drug HER2 Inhibitors for NSCLC Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Targeted Drug HER2 Inhibitors for NSCLC Revenue Market Share by Application (2020-2025)
Table 30. Global Targeted Drug HER2 Inhibitors for NSCLC Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Targeted Drug HER2 Inhibitors for NSCLC Revenue Market Share by Application (2026-2031)
Table 32. North America Targeted Drug HER2 Inhibitors for NSCLC Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Targeted Drug HER2 Inhibitors for NSCLC Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Targeted Drug HER2 Inhibitors for NSCLC Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Targeted Drug HER2 Inhibitors for NSCLC Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Targeted Drug HER2 Inhibitors for NSCLC Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Targeted Drug HER2 Inhibitors for NSCLC Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Targeted Drug HER2 Inhibitors for NSCLC Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Targeted Drug HER2 Inhibitors for NSCLC Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Targeted Drug HER2 Inhibitors for NSCLC Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Targeted Drug HER2 Inhibitors for NSCLC Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Targeted Drug HER2 Inhibitors for NSCLC Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Targeted Drug HER2 Inhibitors for NSCLC Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Targeted Drug HER2 Inhibitors for NSCLC Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Targeted Drug HER2 Inhibitors for NSCLC Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Targeted Drug HER2 Inhibitors for NSCLC Market Size by Country (2026-2031) & (US$ Million)
Table 47. Boehringer-Ingelheim Company Details
Table 48. Boehringer-Ingelheim Business Overview
Table 49. Boehringer-Ingelheim Targeted Drug HER2 Inhibitors for NSCLC Product
Table 50. Boehringer-Ingelheim Revenue in Targeted Drug HER2 Inhibitors for NSCLC Business (2020-2025) & (US$ Million)
Table 51. Boehringer-Ingelheim Recent Development
Table 52. Roche Company Details
Table 53. Roche Business Overview
Table 54. Roche Targeted Drug HER2 Inhibitors for NSCLC Product
Table 55. Roche Revenue in Targeted Drug HER2 Inhibitors for NSCLC Business (2020-2025) & (US$ Million)
Table 56. Roche Recent Development
Table 57. Mylan Company Details
Table 58. Mylan Business Overview
Table 59. Mylan Targeted Drug HER2 Inhibitors for NSCLC Product
Table 60. Mylan Revenue in Targeted Drug HER2 Inhibitors for NSCLC Business (2020-2025) & (US$ Million)
Table 61. Mylan Recent Development
Table 62. Biocon Company Details
Table 63. Biocon Business Overview
Table 64. Biocon Targeted Drug HER2 Inhibitors for NSCLC Product
Table 65. Biocon Revenue in Targeted Drug HER2 Inhibitors for NSCLC Business (2020-2025) & (US$ Million)
Table 66. Biocon Recent Development
Table 67. Research Programs/Design for This Report
Table 68. Key Data Information from Secondary Sources
Table 69. Key Data Information from Primary Sources
Table 70. Authors List of This Report
List of Figures
Figure 1. Targeted Drug HER2 Inhibitors for NSCLC Picture
Figure 2. Global Targeted Drug HER2 Inhibitors for NSCLC Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Targeted Drug HER2 Inhibitors for NSCLC Market Share by Type: 2024 VS 2031
Figure 4. Afatinib Features
Figure 5. Trastuzumab Features
Figure 6. Others Features
Figure 7. Global Targeted Drug HER2 Inhibitors for NSCLC Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Targeted Drug HER2 Inhibitors for NSCLC Market Share by Application: 2024 VS 2031
Figure 9. Squamous Cell Carcinoma of NSCLC Case Studies
Figure 10. Adenocarcinoma of NSCLC Case Studies
Figure 11. Large Cell Carcinoma of NSCLC Case Studies
Figure 12. Targeted Drug HER2 Inhibitors for NSCLC Report Years Considered
Figure 13. Global Targeted Drug HER2 Inhibitors for NSCLC Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Targeted Drug HER2 Inhibitors for NSCLC Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Targeted Drug HER2 Inhibitors for NSCLC Market Share by Region: 2024 VS 2031
Figure 16. Global Targeted Drug HER2 Inhibitors for NSCLC Market Share by Players in 2024
Figure 17. Global Top Targeted Drug HER2 Inhibitors for NSCLC Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Targeted Drug HER2 Inhibitors for NSCLC as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by Targeted Drug HER2 Inhibitors for NSCLC Revenue in 2024
Figure 19. North America Targeted Drug HER2 Inhibitors for NSCLC Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America Targeted Drug HER2 Inhibitors for NSCLC Market Share by Country (2020-2031)
Figure 21. United States Targeted Drug HER2 Inhibitors for NSCLC Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada Targeted Drug HER2 Inhibitors for NSCLC Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Targeted Drug HER2 Inhibitors for NSCLC Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Targeted Drug HER2 Inhibitors for NSCLC Market Share by Country (2020-2031)
Figure 25. Germany Targeted Drug HER2 Inhibitors for NSCLC Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France Targeted Drug HER2 Inhibitors for NSCLC Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. Targeted Drug HER2 Inhibitors for NSCLC Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy Targeted Drug HER2 Inhibitors for NSCLC Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia Targeted Drug HER2 Inhibitors for NSCLC Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries Targeted Drug HER2 Inhibitors for NSCLC Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Targeted Drug HER2 Inhibitors for NSCLC Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Targeted Drug HER2 Inhibitors for NSCLC Market Share by Region (2020-2031)
Figure 33. China Targeted Drug HER2 Inhibitors for NSCLC Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan Targeted Drug HER2 Inhibitors for NSCLC Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea Targeted Drug HER2 Inhibitors for NSCLC Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia Targeted Drug HER2 Inhibitors for NSCLC Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India Targeted Drug HER2 Inhibitors for NSCLC Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia Targeted Drug HER2 Inhibitors for NSCLC Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Targeted Drug HER2 Inhibitors for NSCLC Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Targeted Drug HER2 Inhibitors for NSCLC Market Share by Country (2020-2031)
Figure 41. Mexico Targeted Drug HER2 Inhibitors for NSCLC Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil Targeted Drug HER2 Inhibitors for NSCLC Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Targeted Drug HER2 Inhibitors for NSCLC Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Targeted Drug HER2 Inhibitors for NSCLC Market Share by Country (2020-2031)
Figure 45. Turkey Targeted Drug HER2 Inhibitors for NSCLC Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia Targeted Drug HER2 Inhibitors for NSCLC Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE Targeted Drug HER2 Inhibitors for NSCLC Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Boehringer-Ingelheim Revenue Growth Rate in Targeted Drug HER2 Inhibitors for NSCLC Business (2020-2025)
Figure 49. Roche Revenue Growth Rate in Targeted Drug HER2 Inhibitors for NSCLC Business (2020-2025)
Figure 50. Mylan Revenue Growth Rate in Targeted Drug HER2 Inhibitors for NSCLC Business (2020-2025)
Figure 51. Biocon Revenue Growth Rate in Targeted Drug HER2 Inhibitors for NSCLC Business (2020-2025)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed
